학술논문
Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial
Document Type
Short Communication
Author
Source
In Kidney International February 2024 105(2):381-388
Subject
Language
ISSN
0085-2538